Glutaryl-Coa Dehydrogenase Deficiency has emerging NIH research funding with 3 grants totaling $3.1M.
1 new grant started in the last 12 months.
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Glutaryl-Coa Dehydrogenase Deficiency. Strongest funded area: Translational / Drug Development. Largest gap: Epidemiology / Natural History.
7 publications in Diagnostic / Biomarker but no NIH-funded grants found in Biomarker / Diagnostics for glutaryl-CoA dehydrogenase deficiency. Existing research activity suggests this may be a viable area for grant applications.
17 publications in Case Report / Case Series but no NIH-funded grants found in Epidemiology / Natural History for glutaryl-CoA dehydrogenase deficiency. Existing research activity suggests this may be a viable area for grant applications.
5 publications in Clinical Trial Publication but no NIH-funded grants found in Clinical Research for glutaryl-CoA dehydrogenase deficiency. Existing research activity suggests this may be a viable area for grant applications.
10 publications in Epidemiology / Natural History but no NIH-funded grants found in Epidemiology / Natural History for glutaryl-CoA dehydrogenase deficiency. Existing research activity suggests this may be a viable area for grant applications.
Track funding opportunities for Glutaryl-Coa Dehydrogenase Deficiency.
Follow this disease to be notified about new NIH grants and funding changes.
Already have an account? Sign in to manage your watchlists.